Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medication risk mitigation system and method

a medication risk and management system technology, applied in the field of computer implemented medication risk management, can solve problems such as potential harms, prescribers and pharmacists are unable to combine intrinsic and extrinsic components, and patients and society are burdened by emergency room visits and hospitalizations, so as to achieve the effect of reducing medication risk

Active Publication Date: 2015-06-25
CAREKINESIS
View PDF7 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a method for managing a patient's medication regime to mitigate risks associated with prescribed medications. The method includes an initializing step, a concurrent intervention and a retrospective intervention. The method involves receiving a medication input from a prescriber, comparing it to various data sources to check for contraindications, and making any necessary modifications to the medication. The resulting prescribed medications or revised prescribed medications are then dispensed by a pharmacist. The technical effects of the invention include reducing the risk of medication-related harm, improving treatment efficacy, and promoting patient safety.

Problems solved by technology

Patients and society are burdened by emergency room visits and hospitalizations that often result from misadventures with prescription medications.
Currently, prescribers and pharmacists are unable to combine intrinsic and extrinsic components in a way that provides meaningful interventions with adequate procedures in place to avoid not only harmful interactions between two or more drugs, but also see potential harms related to other intrinsic components that may be patient-specific.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medication risk mitigation system and method
  • Medication risk mitigation system and method
  • Medication risk mitigation system and method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011]The Medication Risk Mitigation (MRM) system of the instant invention applies an array of evidenced-based components and numerous personalized components (e.g., pharmacogenomics, renal function, etc.) to enhance medication safety by individualizing a medication care plan. The system of the instant invention also invokes an assortment of patient-specific interventions to measurably improve medication adherence. The system of the instant invention utilizes a computer program product comprising a non-transitory computer readable medium having program instructions stored in a memory device, the instructions executable by a processor to direct the performance of operations for the management of a regimen for a patient's use of prescribed medication. This MRM process distinctively integrates a medication decision support web / cloud MRM platform with pharmacists and prescribers in order to minimize the pandemic of medication-related morbidity and mortality, while decreasing the rate an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A medication risk mitigation method utilizing three interventions: a prospective intervention performed by a prescriber, a concurrent intervention performed by a pharmacist and a retroactive intervention performed by a pharmacist. At each intervention, the system of the instant invention utilizes a computer program to compare each prescribed medication to a series of intrinsic and extrinsic data sources in order to identify potential contraindications and, if necessary, modify a prescription. The system also permits secure messaging between prescribers and pharmacists, each with access to the computer program, so as to facilitate communication and reduce medication risks. The system of this invention also permits modeling for hypothetical medication modifications based on the same intrinsic and extrinsic data sources.

Description

CROSS REFERENCE TO RELATED APPLICATION(S)[0001]This application claims the benefit of U.S. Provisional Application No. 61 / 920,052, filed Dec. 23, 2013.FIELD OF THE INVENTION[0002]The present invention relates in general to computer implemented medication risk management and, more specifically, reducing the likelihood of patient harm arising from prescribed medications.BACKGROUND OF THE INVENTION[0003]Patients routinely take one or more prescribed medications to treat illnesses. The pandemic of medication-related morbidity and mortality and the increasing rate and cost of medication-induced injuries is also well known in the art. Patients and society are burdened by emergency room visits and hospitalizations that often result from misadventures with prescription medications. Fortunately, disparate data sources provide useful insights into the interactions between two or more medications. Other data sources, referred to herein as intrinsic components, include personalized information ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G06F19/00G16H20/10G16H40/67
CPCG06F19/3431G06F19/322G06F19/3456G16H10/60G16H50/30G16H40/67G16H20/10
Inventor KNOWLTON, CALVIN H.
Owner CAREKINESIS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products